Skip to Main Content

Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes

Conditions

Children's Health | Diseases of the Endocrine System | Immune System | Women's Health

What is the purpose of this trial?

This research study is designed to look at differences in responsiveness to the subcutaneous injection of a standardized dose of rapid-acting insulin analog and blood glucose variability during different phases of the menstrual cycle in females with type 1 diabetes (T1D).

  • Ages
    12 years - 35 years
  • Gender
    Female only
  • Trial with
    Aptitude Medical Systems Inc
  • Start Date
    04/11/2016
  • End Date
    09/29/2018
Trial Image

For more information about this study, contact:

Kristen Kraemer

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1509016531